Photo:
faculty.mdanderson.org
Jun 27, 2026, 13:40
Naveen Pemmaraju: Pacritinib Versus Momelotinib in Thrombocytopenic Myelofibrosis
Naveen Pemmaraju, Executive Director-Cancer Medicine for MDACC Cancer Network, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Expert Review of Hematology, adding:
“Pleased to share our brand new collaborative MPN paper just published in Expert Review of Hematology!”
Title: Efficacy of pacritinib versus momelotinib in patients with thrombocytopenic myelofibrosis: a matching-adjusted indirect treatment comparison
Authors: Naveen Pemmaraju, Alessandro Lucchesi, Stephen T Oh, Koo Wilson, Zalmai Hakimi, Sarah A Buckley, Purvi Suthar, Mikolaj Parkitny, Piotr Wojciechowski, Klaudia Kolonko, John O Mascarenhas
Stay updated on all scientific advances with Hemostasis Today.
Alessandro Lucchesi
Expert Review of Hematology
Health
Hematology
Hemostasis
Hemostasis News
Hemostasis Today
John O Mascarenhas
Klaudia Kolonko
Koo Wilson
Medicine
Mikolaj Parkitny
Momelotinib
MPN
Naveen Pemmaraju
Pacritinib
Piotr Wojciechowski
Purvi Suthar
Sarah A Buckley
Stephen T Oh
thrombosis
Zalmai Hakimi
-
Jun 27, 2026, 13:27Limited-Time Open Access for the EAHAD 2026 Joint Session with ISTH – EAHAD
-
Jun 27, 2026, 13:16Stefano Rivella: Stress Erythropoiesis and the Role of HRG1-Mediated Heme Import
-
Jun 27, 2026, 13:10Yahya Samadi: Luspatercept Shows Promise in Reducing Transfusion Burden in β-Thalassemia
-
Jun 27, 2026, 13:03Margarida Marreiros: Supporting Excellence in Hemostasis Testing
-
Jun 27, 2026, 12:44Maia Meier: Turning Achievement into Advocacy for Women with Bleeding Disorders
-
Jun 27, 2026, 12:38BSH Guideline for the Estimation of Fetomaternal Haemorrhage
-
Jun 27, 2026, 12:34Vishnu K: The Growing Role of RET-He in Modern Hematology
-
Jun 27, 2026, 12:33María Gabriela Muñoz: TOAST Criteria and Outcomes in Ischemic Stroke
-
Jun 27, 2026, 12:17Navid Radfar: Moving Beyond CHA₂DS₂-VASc and De-Risking Atrial Fibrillation